跳至主要内容
临床试验/IRCT20121208011689N6
IRCT20121208011689N6已完成3 期

Effect of curcumin supplementation on serum levels of advanced glycation end products , tumor necrosis factor alpha and metabolic indices in patients with diabetic retinopathy

Tabriz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • Desire to cooperate and sign informed consent form after full knowledge of the goals and method of implementation of the study
  • Age between 40 to 70 years old
  • People with diabetic retinopathy without insulin

排除标准

  • Receiving insulin
  • Cases of chronic diseases such as cardiovascular, renal and hepatic disorders
  • Malabsorption syndrome and inflammatory bowel disease (Crohn's disease, celiac sproctomy, short stomach and biliary tract jejuni-ileal syndrome)
  • Having certain physiological conditions like pregnancy and breastfeeding

研究者

相似试验

Effect of Curcumin in treatment of diabetic... | 临床试验